中国利郎 01234.HK 深 沪
交易中 09-17 13:40:37
3.640
+0.020
+0.55%
华盛通- 最 高3.640
- 今 开3.620
- 成交量 44.00万股
- 最 低 3.610
- 昨 收 3.620
- 总市值 43.59亿
- 52周最高 4.530
- 市盈率 静 8.89
- 换手率 0.00%
- 52周最低 3.040
- 委 比 21.16%
- 总股本 11.97亿
- 历史最高 3.780
- 量 比 1.42
- 振 幅 0.83%
- 历史最低 -2.976
- 每 手 1000
- 风险率 0.16%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Foremost Clean Energy Announces 2,500 Metre Drill Program at its Jean Lake Gold-Lithium Property
Foremost Clean Energy Ltd. announces a 20-hole, 2,500-meter diamond drill program to expand high-grade gold and lithium mineralization at its Jean Lake Gold-Lithium Property in Manitoba, capitalizing on record gold prices. Concurrent with ongoing uranium drilling at its Murphy Lake property, the initiative aims to maximize shareholder value. High-grade gold intercepts include 102 g/t Au over 0.48m, and lithium results show 1.26% Li₂O over 3.35m. ...
09-16 13:00
【生技新天王誕生】禾榮科掛牌首日狂飆近30% 中籤戶每張現賺17.6萬！
禾荣科技（7799）今日以600元承銷價掛牌上市，早盤大漲近三成，盤中最高衝上776元。該公司聚焦加速器型硼中子捕獲治療（AB-BNCT）技術，已接獲12億元訂單，預計2027年完成交付。董事長許金榮表示，BNCT技術適應症擴展至多類癌症，全球市場將迎爆發性成長。禾榮科還自主開發治療用藥BPA，預計2026年底取得藥證，營收結構將更加多元。中期計劃拓展至亞太地區，長期目標布局欧美市場，致力成為全球癌症精準治療領導品牌。
09-15 03:34
Rectitude Reports Green-Energy Progress Ten Months After Launch of AIMS System
Rectitude Holdings Ltd. has made significant progress in expanding its green energy solutions in Southeast Asia since launching the All-in-One Intelligence Micro-Grid System (AIMS) in November 2024. Over the past 10 months, the company has secured AIMS sales contracts in Thailand, delivered products to Singapore and Malaysia, started rental operations in Singapore, and formed strategic partnerships, including one with Agentis Intelligence to boos...
09-11 12:00
Globavend Presents First Half 2025 Financial Results
Globavend Holdings Limited reported a 63.7% revenue increase for the first half of 2025, marking accelerated business growth. The company, which provides end-to-end logistics solutions in Hong Kong, Australia, and New Zealand, primarily serves enterprise e-commerce customers. Despite the revenue surge, net income fell to $450,256 from $898,795 annually, while earnings per share decreased to $6.01 from $12.57. The firm plans to expand its market p...
09-09 20:10
Zenta Group Company Limited Announces Pricing of Initial Public Offering
Zenta Group, a Macau-based professional services provider, announced the pricing of its IPO offering 1,500,000 ordinary shares at $4.00 per share, raising $6 million. The shares are listed on Nasdaq under "ZGM" and trading began on September 9, 2025. The company granted underwriters a 45-day option to purchase an additional 225,000 shares. Proceeds will be used for business growth in Macau, Hong Kong, and Southeast Asia, fintech development, bran...
09-09 15:00
Sagtec Issues Q3 2025 Financial Guidance With 219% Revenue Growth
Sagtec Global Limited reported Q3 2025 financial guidance, projecting a 219% revenue increase to US$17.9 million, a 51% rise in operating cash flow to US$1.27 million, and an 82% net profit growth to US$2.32 million. The growth is driven by expanding adoption of its RaaS and SaaS platforms across hospitality, logistics, and smart retail, alongside regional expansion into the USA, Asia, and the Middle East. The company is focusing on standardizing...
09-09 13:33
Stardust Power Completes Front End Loading 3 Report (FEL 3) for Its Oklahoma Lithium Refinery
Stardust Power Inc. has completed its FEL 3 report for a lithium processing facility in Oklahoma, detailing Phase 1 capacity of 25,000 metric tons per annum of battery-grade lithium, expandable to 50,000 metric tons in Phase 2. Capital expenditures for Phase 1 are estimated at $500 million, nearly $200 million below prior estimates, with a 90% probability of achievement. Construction is expected to take 24 months. The project aims to enhance U.S....
09-09 11:30
Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market
Gelteq Limited plans to initiate a preclinical bioequivalence study in September 2025 for its novel gel-based antihistamine formulation, aiming to seek FDA approval via the 505(b)(2) pathway. If successful, the study will lead to human clinical trials. The gel-based delivery platform addresses key challenges such as patient compliance, precise dosing, and palatability, particularly in paediatrics and veterinary care. With a global antihistamine m...
09-05 15:26
中国利郎（01234.HK）9月4日收盘跌1.38%
证券之星消息，截至2025年9月4日收盘，中国利郎(01234.HK)报收于3.57港元，下跌1.38%，成交量75.8万股，成交额271.69万港元。
09-04 18:21
IDG、阳光保险、腾讯持股的“轻松健康集团”再次递表，冲刺港股IPO
轻松健康集团于2025年8月31日向港交所递交招股书，拟在香港主板上市，联席保荐人为中金公司和招商证券国际。公司是中国领先的科技型一站式平台，专注于提供综合健康服务及健康保险解决方案。2024年收入约9.45亿人民币，净利润约0.1亿人民币；2025年上半年收入6.56亿人民币，净利润0.86亿人民币。根据弗若斯特沙利文数据，公司在中国数字综合健康服务及健康保险服务市场排名第十，数字健康服务市场排名第七。截至2025年6月30日，注册用户数量约1.68亿，保险产品的年化保费总额达4.93亿元，市场渗透率持续提升。
09-03 17:44
